Technical Analysis for DXCM - DexCom, Inc.

Grade Last Price % Change Price Change
grade C 411.15 -2.39% -10.07
DXCM closed down 2.39 percent on Tuesday, August 11, 2020, on 74 percent of normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Flat Down
Historical DXCM trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 20 DMA Bearish -2.39%
MACD Bearish Signal Line Cross Bearish -2.39%
50 DMA Support Bullish -2.39%
Slingshot Bullish Bullish Swing Setup -2.39%
Bollinger Band Squeeze Range Contraction -2.39%
BB Squeeze + Lower Band Touch Range Contraction -2.39%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its ambulatory product line includes SEVEN PLUS, DexCom G4 system, and DexCom G4 PLATINUM system for adults with diabetes to detect trends and track glucose patterns, to aid in the detection of hypoglycemia and hyperglycemia, and to facilitate acute and long-term therapy adjustments. The company's in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. It also offers SweetSpot, a software platform that enables patients to aggregate and analyze data from diabetes devices and to share it with their healthcare providers. The company markets its products directly to endocrinologists, physicians, and diabetes educators primarily in the United States. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Medicine Diabetes Healthcare Providers Endocrine System Diabetes Mellitus Medical Monitoring Software Platform Endocrinology Blood Glucose Monitoring Continuous Glucose Monitor Hyperglycemia Hypoglycemia

Is DXCM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 456.23
52 Week Low 138.28
Average Volume 1,101,101
200-Day Moving Average 298.51
50-Day Moving Average 409.45
20-Day Moving Average 428.48
10-Day Moving Average 434.34
Average True Range 19.82
ADX 13.97
+DI 19.42
-DI 22.63
Chandelier Exit (Long, 3 ATRs ) 396.76
Chandelier Exit (Short, 3 ATRs ) 440.59
Upper Bollinger Band 449.76
Lower Bollinger Band 407.19
Percent B (%b) 0.09
BandWidth 9.93
MACD Line 5.30
MACD Signal Line 8.00
MACD Histogram -2.7027
Fundamentals Value
Market Cap 35.62 Billion
Num Shares 86.6 Million
EPS -0.76
Price-to-Earnings (P/E) Ratio -540.99
Price-to-Sales 6.08
Price-to-Book 10.87
PEG Ratio -1.59
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 435.24
Resistance 3 (R3) 435.25 427.23 431.23
Resistance 2 (R2) 427.23 421.10 427.23 429.89
Resistance 1 (R1) 419.19 417.30 415.18 419.18 428.55
Pivot Point 411.17 411.17 409.17 411.17 411.17
Support 1 (S1) 403.13 405.04 399.12 403.12 393.75
Support 2 (S2) 395.11 401.24 395.11 392.41
Support 3 (S3) 387.07 395.11 391.08
Support 4 (S4) 387.06